Form D — Lyora Therapeutics, Inc.
0002058969-25-000001 · filed Mar 11, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,000,000
- Total sold
- $525,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Lyora Therapeutics, Inc.
- CIK
- 2058969
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 118 GODEN STREET
BELMONT, MA 02478 - Phone
- 2157764288
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Luc Vandenberghe, PhD · Executive OfficerBelmont, MA Find on LinkedIn ↗
-
Eric Pierce, MD, PhD · DirectorBelmont, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗